OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells
Katie C. Coate, Jeeyeon Cha, Shristi Shrestha, et al.
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 1028-1040.e4
Open Access | Times Cited: 167

Showing 1-25 of 167 citing articles:

SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
Janis A. Müller, Rüdiger Groß, Carina Conzelmann, et al.
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 149-165
Open Access | Times Cited: 507

SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment
Chien-Ting Wu, Peter V. Lidsky, Yinghong Xiao, et al.
Cell Metabolism (2021) Vol. 33, Iss. 8, pp. 1565-1576.e5
Open Access | Times Cited: 300

Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
Ioannis P. Trougakos, Κimon Stamatelopoulos, Evangelos Terpos, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 240

Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
Daniel J. Drucker
Cell Metabolism (2021) Vol. 33, Iss. 3, pp. 479-498
Open Access | Times Cited: 239

COVID-19 and metabolic disease: mechanisms and clinical management
Charlotte Steenblock, Peter E. H. Schwarz, Barbara Ludwig, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 11, pp. 786-798
Open Access | Times Cited: 206

Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Ioannis P. Trougakos, Evangelos Terpos, Harry Alexopoulos, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 7, pp. 542-554
Open Access | Times Cited: 196

SARS-CoV-2 infection induces beta cell transdifferentiation
Xuming Tang, Skyler Uhl, Tuo Zhang, et al.
Cell Metabolism (2021) Vol. 33, Iss. 8, pp. 1577-1591.e7
Open Access | Times Cited: 168

Viral infiltration of pancreatic islets in patients with COVID-19
Charlotte Steenblock, Stefanie Richter, Ilona Berger, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 166

Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2
Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, et al.
Cell Metabolism (2021) Vol. 33, Iss. 11, pp. 2174-2188.e5
Open Access | Times Cited: 161

Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19
Irina Kusmartseva, Wenting Wu, Farooq Syed, et al.
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 1041-1051.e6
Open Access | Times Cited: 160

Can COVID-19 cause diabetes?
Domenico Accili
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 123-125
Open Access | Times Cited: 127

New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic
Heli Salmi, Santtu Heinonen, Johanna Hästbacka, et al.
Archives of Disease in Childhood (2021) Vol. 107, Iss. 2, pp. 180-185
Closed Access | Times Cited: 117

Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry
Clemens Kamrath, Joachim Rosenbauer, Alexander J. Eckert, et al.
Diabetes Care (2022) Vol. 45, Iss. 8, pp. 1762-1771
Open Access | Times Cited: 108

COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Mohamd A. Alblihed, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 107

Impact of COVID-19 on the Endocrine System: A Mini-review
Sophie Clarke, Ali Abbara, Waljit S. Dhillo
Endocrinology (2021) Vol. 163, Iss. 1
Open Access | Times Cited: 100

COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences
Berenice Martínez-Salazar, Melle Holwerda, Chiara Stüdle, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 85

Advances in Pancreatic Islet Transplantation Sites for the Treatment of Diabetes
Fritz Cayabyab, Lina R. Nih, Eiji Yoshihara
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 84

COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors
Xi He, Chenshu Liu, Jiangyun Peng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 77

Diabetes and COVID-19; A Bidirectional Interplay
Paraskevi Kazakou, Vaia Lambadiari, Ignatios Ikonomidis, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 64

The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research
Lars Muhl, Liqun He, Ying Sun, et al.
Stem Cell Reports (2022) Vol. 17, Iss. 5, pp. 1089-1104
Open Access | Times Cited: 62

Pathophysiology of infection with SARS‐CoV‐2—What is known and what remains a mystery
Siddharth Sridhar, John Nicholls
Respirology (2021) Vol. 26, Iss. 7, pp. 652-665
Open Access | Times Cited: 58

The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data
Fares Qeadan, Benjamin Tingey, Jamie Egbert, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266809-e0266809
Open Access | Times Cited: 57

Page 1 - Next Page

Scroll to top